Taro Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO PHARMS
TARO PHARMS has two approved drugs.
Summary for Taro Pharms
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms North | PSORCON | diflorasone diacetate | CREAM;TOPICAL | 020205-001 | Nov 20, 1992 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | |||||
| Taro Pharms Ireland | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 078014-001 | Mar 21, 2008 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
